Xylem to acquire Evoqua in $7.5B all-stock deal; 0.48 exchange ratio, ~29% premium

Xylem Inc.

Enterprise value ~$7.5B; Evoqua shareholders receive 0.48 Xylem shares per share, valued at ~$52.89, a 29% premium.
Combined revenue over $7B in trailing 12 months; expected run-rate cost synergies of $140M within three years.
Evoqua shareholders will own ~25% of combined company; Xylem shareholders ~75%.
Transaction expected to close mid-2023, subject to shareholder and regulatory approvals and customary conditions.
President and CEO Patrick Decker to lead combined company; two Evoqua board members to join Xylem board.

item 1.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Xylem Inc. entered into Agreement and Plan of Merger with Evoqua Water Technologies Corp. (effective 2023-01-22).

Action: entry
Agreement: merger
Counterparty: Evoqua Water Technologies Corp.
Effective: 2023-01-22

Exact text from the filing

On January 22, 2023, Xylem Inc. (“Xylem”) and Fore Merger Sub, Inc., a wholly owned subsidiary of Xylem (“Merger Sub”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Evoqua Water Technologies Corp. (“Evoqua”).

View on SEC.gov

Browse all material agreements →

Xylem Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-012563

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.